DPP-4 Inhibitors offer some advantages over existing oral options for the management of type 2 diabetes such as a negligible risk of hypoglycemia compared with sulfonylureas and, in general, a weight-neutral profile.

Forms, dosages and dosing considerations for pregnancy, breastfeeding, hepatic and renal.

As we approach the holiday season a lot of patients will bring you gifts, and many of them will be handmade creations, including some of the gaudiest sweaters known to mankind. Some people are good enough to design these creations as they go along, but most people have to use …

Woman, 42 years of age. Type 1 diabetes for the past 22 years. I’ve been working with her and reviewing her CGM reports, and teaching about checking patterns before making changes in her pump settings.

Dr. Jeffrey Mechanick talks with Diabetes in Control Publisher Steve Freed at the 2016 AACE Meeting. In part 6 of this Exclusive Interview, Dr. Mechanick explains the changes to the AACE obesity treatment guidelines and how they impact current healthcare behavior.

In this week's conclusion of Homerun Slides: Continuous Glucose Monitoring in the Hospital, computerized glucose regulation in the ICU.

Physiologic effects of incretin hormones: GLP-1 -- The GLP-1 receptor has been detected on numerous organs and tissues. High levels of GLP-1 receptors have been found on pancreatic beta cells, delta cells, endothelial cells, cardiomyocytes, the gastrointestinal tract, and the kidneys.

When I first met Steve Freed 22 years ago, it was because of my desire to get pharmacists involved with a nutritional multilevel marketing company. Although I was a pharmacist, I did not really have an interest or passion for diabetes like I do now. The company I was involved …

Premarket Approval application submitted for Eversense® CGM system.

Sucralose may adversely affect glucose metabolism.